Treatment of solid tumors using bispecific anti-PDL-1/ICOS antibody

Perez-Santos, M; Anaya-Ruiz, M; Sanchez-Esgua, G; Villafana-Diaz, L; Barron-Villaverde, D

Perez-Santos, M (corresponding author), Benemerita Univ Autonoma Puebla, Direct Innovac & Transferencia Conocimiento, Puebla 72570, Mexico.

PHARMACEUTICAL PATENT ANALYST, 2021; 10 (2): 67

Abstract

PD-L1 and ICOS are immune control points in cancer and their presence in cancer tends to have a poor prognosis. WO2019122882 patent describes a bispec......

Full Text Link